FDA Inspection
BAYER PHARMA, AGBAYER PHARMA, AG – FDA Inspection, Jan 24, 2017
Record Details
This FDA Inspection record concerns BAYER PHARMA, AG, with an inspection on January 24, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5e47f2e1-951b-482a-ad43-bb89fe81b130
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1001127
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of BAYER PHARMA, AG
9| Date | Classification | Office | Project area |
|---|---|---|---|
| June 6, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 27, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 24, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 3, 2017 | Not classified | Office of Inspections and Investigations | |
| May 13, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BAYER PHARMA, AG
- FDA Inspection 1282736 - 2024-06-06
- FDA Inspection 1239178 - 2021-08-27
- FDA Inspection 1102816 - 2019-09-24
- FDA Inspection 1023408 - 2017-07-03
- FDA Inspection 889209 - 2014-05-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.